Crispr Qc's Kiana Aran one of three inaugural winners of the Sony Women in Technology Award with Nature

Bioengineering Professor Kiana Aran is one of three inaugural winners of the Sony Women in Technology Award with Nature. She is recognized for her pioneering work fusing biology with electronics to enhance precision medicine—including the development of CRISPR-Chip, a CRISPR-powered electronic chip designed to detect genetic mutations in real time. The award is a collaboration between the Sony Group Corporation and Nature.

Crispr is a Serra Capital II and Serra Capital II Follow-On Fund company. Congratulations to Kiana!

To see the full press release, follow here.

Crispr QC’s Ross Bundy Unveils New Secrets to Startup Funding

There is no better time to be a startup, yet fundraising takes a good deal of grit and resilience. It also requires a solid understanding of market trends, investor sentiments, and evolving strategies. As entrepreneurs strive to secure funding for their ventures, they encounter a multitude of challenges and opportunities shaped by economic shifts, investor preferences, and industry dynamics that mean you need to “know your stuff” and be willing to go to battle. 

CRISPR QCs founder Ross Bundy knows. With almost a decade of entrepreneurial experience in the biotechnology sector along with co-founding and scaling two successful companies, Cardea Bio Inc. and CRISPR QC (both of which are transforming the fields of diagnostics, therapeutics, and bioinformatics), Ross understands the nuances of securing investments in today’s competitive landscape.

Read further to hear what Serra II Company Crispr QC’s CEO Ross Bundy, has to say about this topic.